Latest immunotherapy news
FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma
posted June 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
posted June 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
